Indicators
Indicators
Value
Direction
MACD(12,26,9)
0.144
Buy
RSI(14)
68.906
Neutral
STOCH(KDJ)(9,3,3)
78.643
Neutral
ATR(14)
1.761
High Vlolatility
CCI(14)
73.664
Neutral
Williams %R
25.653
Buy
TRIX(12,20)
1.306
Sell
StochRSI(14)
0.000
Oversold
Search
Astrana Health Inc
ASTHAdd to Watchlist
38.260USD
-0.900-2.30%
Close 05/15, 16:00（ET）Quotes delayed by 15 min
1.87BMarket Cap
62.15P/E TTM
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score of Astrana Health Inc
Currency: USD Updated: 2026-05-15Key Insights
Astrana Health Inc's fundamentals are relatively healthy, with an industry-leading ESG disclosure.and its growth potential is high.Its valuation is considered fairly valued, ranking 22 out of 74 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 44.56.In the medium term, the stock price is expected to trend up.The company has been performing strongly in the stock market over the past month, which is supported by its strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Astrana Health Inc's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
Very Low
Very High
Neutral
Astrana Health Inc Highlights
StrengthsRisks
Astrana Health, Inc. is a physician-centric, artificial intelligence (AI)-powered healthcare company focused on delivering patient-centered care. The Company provides care coordination services to each major constituent of the healthcare delivery system, including patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The Company's segments include Care Partners, Care Delivery, and Care Enablement. Its Care Partners segment is focused on building and managing provider networks by partnering with, empowering, and investing in provider partners aligned on a shared vision for coordinated care delivery. Its Care Delivery organization includes primary care, multi-specialty care, and ancillary care services. Its Care Enablement segment represents a comprehensive platform that integrates clinical, operational, financial, and administrative information. It supports more than 20,000 providers.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 129.46% year-on-year.
Overvalued
The company’s latest PE is 62.15, at a high 3-year percentile range.
Institutional Selling
The latest institutional holdings are 29.89M shares, decreasing 2.59% quarter-over-quarter.
Held by HACAX
Star Investor HACAX holds 317.00 shares of this stock.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
44.556
Target Price
+13.78%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Financial Health
Currency: USD Updated: 2026-05-15The current financial score of Astrana Health Inc is 7.11, ranking 46 out of 74 in the Healthcare Providers & Services industry. Its financial status is stable, and its operating efficiency is average. Its latest quarterly revenue reached 965.10M, representing a year-over-year increase of 55.56%, while its net profit experienced a year-over-year increase of 115.72%.
Score
Financials
6.55
Key Metrics
Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.
Quality of Earnings
6.28
Operational Efficiency
7.16
Growth Potential
9.62
Shareholder Returns
5.95
Astrana Health Inc's Company Valuation
Currency: USD Updated: 2026-05-15The current valuation score of Astrana Health Inc is 7.78, ranking 22 out of 74 in the Healthcare Providers & Services industry. Its current P/E ratio is 62.15, which is 149.04% below the recent high of 154.77 and 60.99% above the recent low of 24.24.
Score
Valuation Dimensions
P/E
P/B
P/S
P/CF
Industry Ranking 22/74
Relevant data have not been disclosed by the company yet.
Earnings Forecast
Currency: USD Updated: 2026-05-15The current earnings forecast score of Astrana Health Inc is 8.55, ranking 10 out of 74 in the Healthcare Providers & Services industry. The average price target is 38.50, with a high of 54.00 and a low of 26.00.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Analyst Rating
Based on
11
analysts
Buy
Current Rating
44.556
Target Price
+13.78%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell
Peer Comparison
68
Total
7
Median
8
Average
Company name
Ratings
Analysts
Astrana Health Inc
ASTH
11
CVS Health Corp
CVS
29
HCA Healthcare Inc
HCA
27
Teladoc Health Inc
TDOC
27
Tenet Healthcare Corp
THC
24
Universal Health Services Inc
UHS
21
1
2
3
...
14
Financial Forecasting
EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Price Momentum
Currency: USD Updated: 2026-05-15The current price momentum score of Astrana Health Inc is 9.28, ranking 17 out of 74 in the Healthcare Providers & Services industry. Currently, the stock price is trading between the resistance level at 41.96 and the support level at 32.53, making it suitable for range-bound swing trading.
Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Indicators
The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.
This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.
Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.
Moving Average
Indicators
Value
Direction
MA5
38.832
Sell
MA10
37.496
Buy
MA20
35.613
Buy
MA50
29.696
Buy
MA100
26.663
Buy
MA200
27.094
Buy
Institutional Confidence
Currency: USD Updated: 2026-05-15The current institutional shareholding score of Astrana Health Inc is 5.00, ranking 49 out of 74 in the Healthcare Providers & Services industry. The latest institutional shareholding proportion is 53.71%, representing a quarter-over-quarter decrease of 7.20%. The largest institutional shareholder is Diamond Hill Capital, holding a total of 544.03K shares, representing 1.10% of shares outstanding, with 159.57% increase in holdings.
Score
Institutional Shareholding
Relevant data have not been disclosed by the company yet.
Risk Assessment
Currency: USD Updated: 2026-05-15The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Providers & Services domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Astrana Health Inc is 4.75, ranking 45 out of 74 in the Healthcare Providers & Services industry. The company's beta value is 1.01. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.
Score
Beta vs S&P 500 index
1.01
VaR
+5.56%
240-Day Maximum Drawdown
+46.41%
240-Day Volatility
+59.94%
Return
Best Daily Return
60 days
+29.46%
120 days
+29.46%
5 years
+30.85%
Worst Daily Return
60 days
-6.88%
120 days
-21.09%
5 years
-26.82%
Sharpe Ratio
60 days
+4.14
120 days
+1.92
5 years
+0.04
Risk Assessment
Maximum Drawdown
240 days
+46.41%
3 years
+70.96%
5 years
+84.80%
Return-to-Drawdown Ratio
240 days
+1.21
3 years
+0.11
5 years
-0.14
Skewness
240 days
+1.07
3 years
+0.08
5 years
+0.14
Volatility
Realised Volatility
240 days
+59.94%
5 years
+61.40%
Standardised True Range
240 days
+3.60%
5 years
+5.91%
Downside Risk-Adjusted Return
120 days
+252.66%
240 days
+252.66%
Maximum Daily Upside Volatility
60 days
+66.65%
Maximum Daily Downside Volatility
60 days
+55.07%
Liquidity
Average Turnover Rate
60 days
+1.00%
120 days
+1.06%
5 years
--
Turnover Deviation
20 days
+38.24%
60 days
+30.25%
120 days
+37.17%
Peer Comparison
Healthcare Providers & Services
Astrana Health Inc
ASTH
7.49 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Encompass Health Corp
EHC
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Concentra Group Holdings Parent Inc
CON
8.39 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Pennant Group Inc
PNTG
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Brightspring Health Services Inc
BTSG
8.34 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Hinge Health Inc
HNGE
8.28 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
